首页> 外文期刊>BMC Health Services Research >Practical considerations to guide development of access controls and decision support for genetic information in electronic medical records
【24h】

Practical considerations to guide development of access controls and decision support for genetic information in electronic medical records

机译:指导在电子病历中遗传信息的访问控制和决策支持的制定的实践考虑因素

获取原文
           

摘要

Background Genetic testing is increasingly used as a tool throughout the health care system. In 2011 the number of clinically available genetic tests is approaching 2,000, and wide variation exists between these tests in their sensitivity, specificity, and clinical implications, as well as the potential for discrimination based on the results. Discussion As health care systems increasingly implement electronic medical record systems (EMRs) they must carefully consider how to use information from this wide spectrum of genetic tests, with whom to share information, and how to provide decision support for clinicians to properly interpret the information. Although some characteristics of genetic tests overlap with other medical test results, there are reasons to make genetic test results widely available to health care providers and counterbalancing reasons to restrict access to these test results to honor patient preferences, and avoid distracting or confusing clinicians with irrelevant but complex information. Electronic medical records can facilitate and provide reasonable restrictions on access to genetic test results and deliver education and decision support tools to guide appropriate interpretation and use. Summary This paper will serve to review some of the key characteristics of genetic tests as they relate to design of access control and decision support of genetic test information in the EMR, emphasizing the clear need for health information technology (HIT) to be part of optimal implementation of genetic medicine, and the importance of understanding key characteristics of genetic tests when designing HIT applications.
机译:背景技术遗传测试越来越多地用作整个医疗保健系统的工具。 2011年,临床上可用的遗传测试的数量正在接近2,000,并且在这些测试之间存在宽松的变化,以及基于结果的歧视潜力。讨论作为医疗保健系统越来越多地实施电子医疗记录系统(EMRS),他们必须仔细考虑如何使用来自这种广泛的遗传测试的信息,与谁共享信息,以及如何为临床医生提供决策支持,以适当地解释信息。虽然遗传检测的一些特征与其他医学测试结果重叠,但有理由产生遗传测试结果,遗传测试结果可供医疗保健提供者和平衡的理由限制对这些测试结果的访问,以履行患者偏好,并避免患有无关紧要的临床医生但复杂的信息。电子医疗记录可以促进并提供对遗传测试结果的获取合理限制,并提供教育和决策支持工具,以指导适当的解释和使用。摘要本文将有助于审查遗传测试的一些关键特征,因为它们与EMR中的遗传测试信息的访问控制和决策支持的设计有关,强调了解健康信息技术(命中)成为最佳的一部分遗传医学的实施,以及在设计打击应用时理解基因试验的关键特征的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号